These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 35595823)

  • 1. STAT1 is regulated by TRIM24 and promotes immunosuppression in head and neck squamous carcinoma cells, but enhances T cell antitumour immunity in the tumour microenvironment.
    Anderson K; Ryan N; Nedungadi D; Lamenza F; Swingler M; Siddiqui A; Satoskar A; Upadhaya P; Pietrzak M; Oghumu S
    Br J Cancer; 2022 Sep; 127(4):624-636. PubMed ID: 35595823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon-alpha promotes immunosuppression through IFNAR1/STAT1 signalling in head and neck squamous cell carcinoma.
    Ma H; Yang W; Zhang L; Liu S; Zhao M; Zhou G; Wang L; Jin S; Zhang Z; Hu J
    Br J Cancer; 2019 Feb; 120(3):317-330. PubMed ID: 30555157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. STAT1 inhibits T-cell exhaustion and myeloid derived suppressor cell accumulation to promote antitumor immune responses in head and neck squamous cell carcinoma.
    Ryan N; Anderson K; Volpedo G; Hamza O; Varikuti S; Satoskar AR; Oghumu S
    Int J Cancer; 2020 Mar; 146(6):1717-1729. PubMed ID: 31709529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. USP39 Promotes the Viability and Migration of Head and Neck Squamous Cell Carcinoma Cell by Regulating STAT1.
    Hu Y; Wang Y; Hu W; Hu C; Wang B; Liu C; Deng A; Shen B; Wu K; Liu Y
    Technol Cancer Res Treat; 2024; 23():15330338241250298. PubMed ID: 38706215
    [No Abstract]   [Full Text] [Related]  

  • 5. A novel IFNα-induced long noncoding RNA negatively regulates immunosuppression by interrupting H3K27 acetylation in head and neck squamous cell carcinoma.
    Ma H; Chang H; Yang W; Lu Y; Hu J; Jin S
    Mol Cancer; 2020 Jan; 19(1):4. PubMed ID: 31907020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TIGIT/CD155 blockade enhances anti-PD-L1 therapy in head and neck squamous cell carcinoma by targeting myeloid-derived suppressor cells.
    Mao L; Xiao Y; Yang QC; Yang SC; Yang LL; Sun ZJ
    Oral Oncol; 2021 Oct; 121():105472. PubMed ID: 34333450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon-alpha enhances the antitumour activity of EGFR-targeted therapies by upregulating RIG-I in head and neck squamous cell carcinoma.
    Ma H; Jin S; Yang W; Zhou G; Zhao M; Fang S; Zhang Z; Hu J
    Br J Cancer; 2018 Feb; 118(4):509-521. PubMed ID: 29348488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E3 Ubiquitin Ligase RNF125 Suppresses Immune Escape in Head and Neck Squamous Cell Carcinoma by Regulating PD-L1 Expression.
    Jiang C; He L; Xiao S; Wu W; Zhao Q; Liu F
    Mol Biotechnol; 2023 Jun; 65(6):891-903. PubMed ID: 36344734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous disturbance of NHE1 and LOXL2 decreases tumorigenicity of head and neck squamous cell carcinoma.
    Hayashi Y; Miyoshi S; Watanabe I; Yano N; Nagashio K; Kaneko M; Kaminota T; Sanada T; Hosokawa Y; Kitani T; Mitani S; Choudhury ME; Yano H; Tanaka J; Hato N
    Auris Nasus Larynx; 2024 Jun; 51(3):472-480. PubMed ID: 38520980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The immunomodulatory ballet of tumour-derived extracellular vesicles and neutrophils orchestrating the dynamic CD73/PD-L1 pathway in cancer.
    Rubenich DS; Domagalski JL; Gentil GFS; Eichberger J; Fiedler M; Weber F; Federlin M; Poeck H; Reichert TE; Ettl T; Bauer RJ; Braganhol E; Schulz D
    J Extracell Vesicles; 2024 Jul; 13(7):e12480. PubMed ID: 38978304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of cancer cell STAT1 improves response to radiation therapy and promotes T cell activation in head and neck squamous cell carcinoma.
    Knitz MW; Darragh LB; Bickett TE; Bhatia S; Bukkapatnam S; Gadwa J; Piper M; Corbo S; Nguyen D; Van Court B; Oweida A; Karam SD
    Cancer Immunol Immunother; 2022 May; 71(5):1049-1061. PubMed ID: 34559306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Black raspberry extract inhibits regulatory T-cell activity in a murine model of head and neck squamous cell carcinoma chemoprevention.
    Ryan NM; Lamenza FF; Upadhaya P; Pracha H; Springer A; Swingler M; Siddiqui A; Oghumu S
    Front Immunol; 2022; 13():932742. PubMed ID: 36016924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HGF-Induced PD-L1 Expression in Head and Neck Cancer: Preclinical and Clinical Findings.
    Boschert V; Teusch J; Aljasem A; Schmucker P; Klenk N; Straub A; Bittrich M; Seher A; Linz C; Müller-Richter UDA; Hartmann S
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33233528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-wide open reading frame profiling identifies fibroblast growth factor signaling as a driver of PD-L1 expression in head and neck squamous cell carcinoma.
    Mann JE; Smith JD; Kulkarni A; Foltin SK; Scheftz EB; Murray IR; Gensterblum-Miller E; Brummel CV; Bhangale A; Hoesli RC; Brenner JC
    Oral Oncol; 2023 Nov; 146():106562. PubMed ID: 37666053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognosis of head and neck squamous cell carcinoma related to immunosuppressive tumor microenvironment regulated by IL-6 signaling.
    Tsai MS; Chen WC; Lu CH; Chen MF
    Oral Oncol; 2019 Apr; 91():47-55. PubMed ID: 30926062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-375 inhibits IFN-γ-induced programmed death 1 ligand 1 surface expression in head and neck squamous cell carcinoma cells by blocking JAK2/STAT1 signaling.
    Wu Q; Zhao Y; Sun Y; Yan X; Wang P
    Oncol Rep; 2018 Mar; 39(3):1461-1468. PubMed ID: 29328389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PD-L1-specific helper T-cells exhibit effective antitumor responses: new strategy of cancer immunotherapy targeting PD-L1 in head and neck squamous cell carcinoma.
    Hirata-Nozaki Y; Ohkuri T; Ohara K; Kumai T; Nagata M; Harabuchi S; Kosaka A; Nagato T; Ishibashi K; Oikawa K; Aoki N; Ohara M; Harabuchi Y; Uno Y; Takei H; Celis E; Kobayashi H
    J Transl Med; 2019 Jun; 17(1):207. PubMed ID: 31221178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of programmed-death ligand in the human head and neck squamous cell carcinoma microenvironment is mediated through matrix metalloproteinase-mediated proteolytic cleavage.
    Hira-Miyazawa M; Nakamura H; Hirai M; Kobayashi Y; Kitahara H; Bou-Gharios G; Kawashiri S
    Int J Oncol; 2018 Feb; 52(2):379-388. PubMed ID: 29345283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CMTM4 regulates epithelial-mesenchymal transition and PD-L1 expression in head and neck squamous cell carcinoma.
    Li H; Liu YT; Chen L; Zhou JJ; Chen DR; Li SJ; Sun ZJ
    Mol Carcinog; 2021 Aug; 60(8):556-566. PubMed ID: 34061408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lactate secreted by PKM2 upregulation promotes Galectin-9-mediated immunosuppression via inhibiting NF-κB pathway in HNSCC.
    Chang H; Xu Q; Li J; Li M; Zhang Z; Ma H; Yang X
    Cell Death Dis; 2021 Jul; 12(8):725. PubMed ID: 34290225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.